Wilms Tumor: Symptoms, Diagnosis, Treatment & Red Flags

Wilms tumor (nephroblastoma) is an embryonal renal malignancy that recapitulates metanephric blastema with variable mixtures of blastemal, stromal, and epithelial elements on histology. It almost always arises in children, classically between two and five years of age, and typically presents as a painless flank or abdominal mass rather than with the painless visible haematuria-first pattern that dominates adult kidney cancer pathways. Tumour biology is tightly linked to several well-characterised predisposition syndromes, and modern outcomes depend on accurate staging (especially pulmonary metastases), histology (favourable versus focal or diffuse anaplasia), and adherence to cooperative-group multimodal protocols combining surgery, chemotherapy, and sometimes radiotherapy.

Unlike adult renal cell carcinoma, Wilms tumor grows as a spherical intrarenal mass that can compress adjacent parenchyma, invade renal sinus vessels, or rupture with resultant intra-abdominal spill—a complication that upstages therapy because tumour cells seed the peritoneum. Hypertension is common when renin secretion is distorted; visible or microscopic haematuria may appear but is seldom the sole presenting complaint. Nursing contributions centre on rapid recognition of mass effects, meticulous chemotherapy administration, prevention of central-line complications, and early detection of treatment toxicity or post-operative haemorrhage.

North American (Children’s Oncology Group–style) and European (SIOP-aligned) approaches differ in whether chemotherapy precedes nephrectomy, but both systems demand precise locoregional staging and systematic evaluation for pulmonary metastases. Chest X-ray remains a first-line screen, yet small pulmonary nodules often require CT imaging of the chest for definitive staging because microscopic lung involvement changes chemotherapy and radiotherapy intensity.

↔On a small screen, swipe or scroll sideways to see the full table.

Parents classically report a firm, non-tender abdominal swelling noticed during bathing; the mass may cross the midline if huge but usually remains unilateral. Abdominal pain can emerge if there is capsular stretch, haemorrhage into the tumour, or adjacent organ compression. Fever is nonspecific but should never be dismissed during chemotherapy. Hypertension may be picked up incidentally at school or GP checks. Compare with leukaemia, where marrow failure dominates early, and with benign renal enlargement from hydronephrosis where ultrasound shows pelvicalyceal dilatation rather than a solid mass.

Most cases are sporadic, yet a substantial minority carry germline or somatic alterations in WT1, WT2/ICR at 11p15 (Beckwith-Wiedemann spectrum), WTX, or other loci implicated in nephrogenic rests. Syndromes such as WAGR, Denys-Drash, and Beckwith-Wiedemann spectrum warrant renal ultrasound surveillance schedules distinct from the general population. Environmental triggers are poorly defined; focus nursing history on growth asymmetry, genitourinary anomalies, hemihypertrophy, and family cancer patterns that should be escalated to genetics.

Initial assessment pairs abdominal examination (avoid aggressive palpation—rupture risk) with abdominal ultrasound to confirm a solid renal mass and document the inferior vena cava patency. Contrast-enhanced cross-sectional imaging of the abdomen and pelvis defines local extension and contralateral kidney status; chest imaging screens for metastases. Urinalysis may show blood in the urine. Full blood count may reveal anaemia from chronic disease or marrow suppression if therapy has started. Biopsy is not routine for classical unilateral resectable masses on North American pathways; when chemotherapy-first protocols apply, percutaneous biopsy is reserved for selected situations and must never be arranged without the paediatric oncology surgeon’s agreement because of seeding risk.

1. Suspect — unexplained abdominal mass, hypertension, or suspicious ultrasound in a young child.
2. Stabilise — treat hypertensive emergencies, correct symptomatic anaemia per protocol, secure two large-bore lines if bleeding risk.
3. Stage — complete abdominal imaging plus chest staging; document baseline weight, GFR estimates, and echocardiogram if anthracyclines planned.
4. Pathway choice — immediate nephrectomy versus neoadjuvant chemotherapy per MDT and cooperative-group assignment.
5. Treat & monitor — surgery timing, chemotherapy cycles, radiotherapy simulation, toxicity labs, and family psychosocial support.
6. Survivorship — late cardiac, renal, endocrine, and second-malignancy surveillance per risk-stratified schedules.

• Neuroblastoma (often adrenal, may cross midline, elevated urinary catecholamines).
• Clear cell sarcoma of the kidney or malignant rhabdoid tumour — distinct biology, different adjuvant plans.
• Hydronephrosis or multicystic dysplastic kidney — ultrasound distinguishes cystic fluid collections.
• Renal vein thrombosis with kidney enlargement — Doppler/clinical context.

Multimodal therapy combines nephrectomy (or delayed nephrectomy after shrinkage), multi-agent chemotherapy (classically vincristine plus dactinomycin with doxorubicin added for higher stage or histology), and flank or whole-abdominal radiotherapy when stage or spill mandates it. Bilateral disease aims for nephron-sparing resections after chemotherapy-induced downstaging. Nurses prepare patients for central line care, ensure IV infusion pump setup matches protocol rates, and execute high-alert medication administration checks for vinca alkaloids and anthracyclines.

Align bedside documentation with the written cooperative-group schedule: cycle day, absolute neutrophil count, platelet threshold for bolus agents, urine output targets, and radiotherapy simulation appointments. Pre-chemotherapy assessment should include mouth inspection, bowel pattern, gait (peripheral neuropathy), and cardiac symptom review. Post-nephrectomy, monitor drain output, wound integrity, pain scores, and creatinine trends in the single-kidney state. Communicate early with play specialists, school liaison teams, and psychology—treatment burden is family-wide.

• Myelosuppression, febrile neutropenia, mucositis.
• Vincristine-related neuropathy and constipation ileus.
• Anthracycline cardiotoxicity—baseline and serial echocardiography per protocol.
• Radiation enteritis or impaired linear growth when abdominal fields are wide.
• Renal hypofunction after bilateral partial resections or radiation.

Population screening is not indicated for average-risk children, but syndrome-specific renal ultrasound programmes are evidence-aligned for Beckwith-Wiedemann spectrum, aniridia, and other high-penetrance predispositions. Nursing’s role is to ensure families attend scheduled imaging, understand warning symptoms between scans, and maintain vaccination and infection-prevention counselling during immunosuppressive phases.

Overall survival for favourable-histology, localised Wilms tumor exceeds 90% in contemporary series from high-income multidisciplinary centres; diffuse anaplasia, advanced metastatic burden at diagnosis, and bilateral disease with incomplete resection worsen outlook. Late effects—cardiac, renal, endocrine, fertility, and second cancers—make structured survivorship clinics essential rather than optional.

Parents may not volunteer that they felt a mass weeks earlier—always ask about clothes fitting tightly, new car-seat strap positions, or slowed running. Use lay language but document objective abdominal girth measurements when directed. When transferring between tertiary and shared-care hospitals, send a one-page flow sheet listing cycle day, last creatinine, last echocardiogram, and whether abdominal radiation is planned—those details determine whether peripheral blood draws are safe and whether G-CSF was given.

• Pre-chemo: height, weight, ANC, platelets, creatinine, LFTs, hearing test if protocol mandates.
• Infusion: line patency, extravasation checks, antiemetic timing, strict I/O.
• Post-op: drain volume/colour, wound, bowel sounds, pain, Hb, creatinine.
• Respiratory: SpO₂, work of breathing, auscultation if pulmonary mets or bleomycin-like agents on trial.
• Neurology: constipation pattern, foot drop, jaw pain—vincristine toxicity ladder.

• Haemodynamic shock, acute abdomen, or suspected tumour rupture.
• Hypertensive emergency or seizure.
• Fever ≥38.0 °C with neutropenia during chemotherapy.
• Sudden pleuritic chest pain with hypoxia.
• Acute urinary anuria with rising creatinine post-operatively.

Escalate to the paediatric oncology registrar or rapid response team when age-adjusted early warning scores climb, urine output falls below protocol thresholds, or new oxygen requirement appears. Bring the chemotherapy flowsheet, latest imaging report, and antihypertensive list to every handover—Wilms patients can flip from stable to critical within hours if bleeding or sepsis supervenes.

Pre-treatment

• Confirm fasting, consent, blood availability, and imaging discs for theatre.
• Baseline neuropathy and cardiac assessments documented.

Active treatment

• Chemotherapy per protocol with independent double-checks.
• Radiotherapy skin care and diarrhoea monitoring when abdominal fields used.

Education

• Teach infection precautions, mouth care, constipation prevention, and when to call the emergency line.

These NCLEX-style clinical judgment practice items focus on the nursing priorities for this condition — recognise cues, escalate red flags, take safe action and evaluate outcomes (NCSBN Clinical Judgment Measurement Model) — through Priority FIRST, SATA, deterioration trends, multi-patient triage, ordered response, and matrix matching on the topic of Wilms tumor staging, nephrectomy timing, pulmonary metastasis surveillance, and chemotherapy safety—mirroring Clinical Judgment Measurement Model priorities (recognise cues → analyse cues → prioritise hypotheses → generate solutions → take actions → evaluate outcomes). Tap Check answers for rationales.